Investors / United States / Bloomfield Partners
Bloomfield Partners
Venture capital · Roanoke, VA, United States · North America
Bloomfield Partners is a software and technology investment firm based in Roanoke, Virginia, founded in 2014. It backs experienced founders with capital and hands-on operating support in product, go-to-market, and scaling.
Invests inHealthcare & Biotech
In its own wordssoftwaretechnologysaasailife sciencesinfrastructure
Your fit with Bloomfield Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBloomfield Partners lists 7 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Pre-seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (44%), AI & Machine Learning (11%) and Fintech (11%). 100% of its companies are based in United States. It invests most often alongside Florida Opportunity Fund, GC Ventures and Golub Growth.
Counts come from funding rounds that name Bloomfield Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundBloomfield Partners does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 100% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 12th | 7 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 79th | 44% in its largest sector |
| Reach | 19th | 1 country |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 44% | 15% |
| AI & Machine Learning | 11% | 18% |
| Fintech | 11% | 12% |
| Industrial & Manufacturing | 11% | 7% |
| Real Estate & Construction | 11% | 3% |
| Education | 11% | 7% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Florida Opportunity Fund | 1 |
| GC Ventures | 1 |
| Golub Growth | 1 |
| Reach Capital | 1 |
| UVA Licensing & Ventures Group | 1 |
| VTC Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers7100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Florida Opportunity Fund
Compare Bloomfield Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Bloomfield Partners| Date | Company | Stage |
|---|---|---|
| 1 Mar 2026 | Pre-Seed |
Round details for Bloomfield Partners
Amounts, full round histories and every co-investor in Bloomfield Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
7 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Acomhal Research is developing a targeted adjunct therapy aimed at tackling chemo-resistant cells in aggressive cancers | Healthcare & Biotech | Portfolio page | ||
| CytoRecovery sells products, including CytoBuffer, and features dielectrophoresis technology for sorting immune cells. | Healthcare & Biotech | Portfolio page | ||
| PlexAI provides investment intelligence for commercial real estate | Real Estate & Construction | Mar 2026Pre-Seed | Funding round | |
| Portfolio page | ||||
| Ideagen provides software management solutions for environmental health and safety, quality, and compliance | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| MemberMax provides software for association management, empowering professional and trade associations to drive revenue, manage events, and operate efficiently. | EducationHealthcare & Biotech | Portfolio page | ||
| The company builds furniture to order and sells it directly to customers | FintechIndustrial & Manufacturing | Portfolio page |
About this data
site last read 6 Nov 2026- Site
- bloomfield-partners.com
- Last read
- 6 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 1 Mar 2026
- Companies checked
- 7
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Bloomfield Partners' profile as data
Pull Bloomfield Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/bloomfield-partners.com
# also
GET /v1/firms/bloomfield-partners.com/portfolio
GET /v1/firms/bloomfield-partners.com/coinvestors
GET /v1/firms/bloomfield-partners.com/news